VPG Venus Pharma Gmbham Bahnhof Pharmaceutical Import Profile — Germany (DGFT 2022–2026)

Name: VPG Venus Pharma Gmbham Bahnhof Pharmaceutical Import Records from India — 2 Products, $859.1K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

VPG Venus Pharma Gmbham Bahnhof — Pharmaceutical Importer Profile (2026) | 2 Products, $859.1K Trade | TransData Nexus

VPG Venus Pharma Gmbham Bahnhof

Pharmaceutical Importer · Germany · Advanced Antibiotics Focus · $859.1K Total Trade · DGFT Verified

VPG Venus Pharma Gmbham Bahnhof is a pharmaceutical importer based in Germany with a total trade value of $859.1K across 2 products in 1 therapeutic categories. Based on 19 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. VPG Venus Pharma Gmbham Bahnhof sources from 1 verified Indian supplier, with Venus Remedies Limited accounting for 100.0% of imports.

VPG Venus Pharma Gmbham Bahnhof — Import Portfolio & Supplier Network

VPG Venus Pharma Gmbham Bahnhof import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to VPG Venus Pharma Gmbham Bahnhof?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Venus Remedies Limited	$864.0K	27	100.0%

VPG Venus Pharma Gmbham Bahnhof sources from 1 verified Indian supplier across 22 distinct formulations. The sourcing is highly concentrated — Venus Remedies Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Meropenem 1.0 GM powder for solution forinjection or infusion meropenem venuspharma 1.0 GM	$150.0K	3
Meropenem 1.0 GM powder for solution forinjection or infusion meropenem enexi1000mg	$131.0K	4
Meropenem 1.0 GM powder for solution forinjection or infusion batch no.x3ga314a,md.07/2023	$50.0K	1
Meropenem 1.0 GM powder for solution forinjection or infusion meropenem 1000 MG	$50.0K	1
Meropenem 500 MG powder for solution forinjection or infusion meropenem 500 MG	$50.0K	1
Ceftazidime powder for solution for injection or infusion 1.0 g ceftazidime venus pharma	$50.0K	1
Meropenem 500 MG powder for solution forinjection or infusion meropenem venuspharma 500MG	$50.0K	1
Meropenem 1.0 GM powder for solution forinjection or infusion meropenem venuspharma 1 GM	$50.0K	1
Meropenem 500MG powder for solution forinjection or infusion meropenem venus pharma 500 MG	$42.4K	1
Carboplatin venus pharma carboplatin concentrate for SOL.for infusion 150 MG/15ML b.n.x3ica011a md.09/23	$35.4K	1
Ceftriaxone for injection usp2000mgeach50ml vial cnt:ceftriaxone sodium USP eq.to ceftriaxone2000mgceftriaxone 2.0GM	$27.9K	1
Cisplatin venus pharma 100MG cisplatinconcentrate for SOL.for inf. 100 MG/100ML b.n.x3ici075a md.09/2023	$27.3K	1
Meropenem 500 MG powder for solution forinjection or infusion meropenem eberth500 MG	$25.5K	1
Ceftazidime powder for solution for injection or infusion 2.0 g ceftazidime venus pharma	$24.7K	1
Meropenem 500 MG powder for solution forinjection or infusion bn.x3ga303a,md.07/2023	$22.9K	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Meropenem	Advanced Antibiotics	$750.0K	15	0.3%	14
2	Ceftazidime	Advanced Antibiotics	$109.1K	4	1.0%	11

VPG Venus Pharma Gmbham Bahnhof imports 2 pharmaceutical products across 1 categories into Germany totaling $859.1K.

VPG Venus Pharma Gmbham Bahnhof — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

VPG Venus Pharma GmbH, headquartered in Werne, Germany, is a pharmaceutical importer specializing in the acquisition of finished pharmaceutical formulations from international suppliers. Established in 2006, the company operates as a subsidiary of Venus Remedies Limited, an Indian pharmaceutical manufacturer. VPG Venus Pharma GmbH plays a pivotal role in Germany's pharmaceutical distribution network by sourcing high-quality medications from global markets and ensuring their availability to healthcare providers and patients within Germany.

2Distribution Network

VPG Venus Pharma GmbH's distribution network is centered around its facility in Werne, Nordrhein-Westfalen, Germany. The company's logistics capabilities are designed to efficiently manage the importation and distribution of pharmaceutical products sourced from international suppliers, particularly from India. While specific details about additional warehouse locations and geographic coverage beyond Germany are not publicly disclosed, the company's strategic position in Werne facilitates effective distribution throughout Germany and potentially to other European markets.

3Industry Role

In Germany's pharmaceutical supply chain, VPG Venus Pharma GmbH functions primarily as a pharmaceutical importer. By sourcing finished pharmaceutical formulations from international suppliers, the company ensures the availability of a diverse range of medications to meet the needs of healthcare providers and patients within Germany. This role is crucial in maintaining a steady supply of essential drugs, particularly in therapeutic areas where local production may be limited or unavailable.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — VPG Venus Pharma Gmbham Bahnhof

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

VPG Venus Pharma GmbH demonstrates a high degree of supplier concentration, with all its imports originating from a single supplier: Venus Remedies Limited. This single-source dependency indicates a strategic choice to maintain a focused and potentially more manageable supply chain. However, the shipment data reveals a consistent relationship, with 27 shipments over the period from 2022 to 2026, suggesting a stable and reliable partnership. While this concentration may offer benefits such as streamlined operations and potentially favorable terms, it also exposes the company to risks associated with over-reliance on a single supplier, including potential disruptions in supply or changes in supplier terms.

2Supply Chain Resilience

The resilience of VPG Venus Pharma GmbH's supply chain is closely tied to its sole supplier, Venus Remedies Limited. The consistent number of shipments over the years indicates a stable supply relationship. However, the lack of backup suppliers introduces a vulnerability; any disruptions at Venus Remedies Limited could significantly impact VPG Venus Pharma GmbH's ability to meet market demand. The company's focus on a limited number of formulations may also reduce its exposure to supply chain risks associated with a broader product range. Ensuring the regulatory compliance of Venus Remedies Limited, particularly adherence to EU-GMP standards, is essential to maintain the integrity and reliability of the supply chain.

Importing Pharmaceuticals into Germany — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Germany

1Regulatory Authority & Framework

In Germany, the primary regulatory authority overseeing pharmaceutical imports is the Federal Institute for Drugs and Medical Devices (BfArM). The key legislation governing pharmaceutical imports includes the German Medicines Act (AMG), which outlines the requirements for the importation, distribution, and marketing of medicinal products. The marketing authorization pathway for Indian generics involves obtaining approval from BfArM, which assesses the safety, efficacy, and quality of the products. Additionally, compliance with EU regulations, including those set by the European Medicines Agency (EMA), is mandatory for all pharmaceutical imports into Germany.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products in Germany stipulate that all imported medicines must have a valid marketing authorization issued by BfArM. Manufacturers and suppliers must adhere to Good Manufacturing Practice (GMP) standards recognized by the European Union, such as EU-GMP, WHO GMP, or PIC/S certifications. These certifications ensure that the manufacturing processes meet stringent quality standards. Additionally, companies must possess wholesale distribution authorization to legally distribute pharmaceutical products within Germany.

Quality & Labeling

VPG Venus Pharma Gmbham Bahnhof — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

VPG Venus Pharma GmbH's product strategy focuses on importing advanced antibiotics, specifically Meropenem and Ceftazidime, which constitute 100% of its imported products. This focus aligns with the growing demand for effective antimicrobial therapies in Germany, driven by the need to combat antibiotic-resistant infections. The company's imports cater to a critical segment of the healthcare market, addressing the urgent need for high-quality antibiotics in hospital and clinical settings.

2Sourcing Profile

VPG Venus Pharma GmbH's sourcing strategy is centered on acquiring generic drugs, particularly advanced antibiotics, from a single supplier, Venus Remedies Limited. The company's preference for finished dosage forms, such as tablets, capsules, syrups, and injections, reflects a focus on ready-to-use products that meet the immediate needs of healthcare providers. India's established reputation for producing high-quality generic pharmaceuticals positions it as a key supplier in VPG Venus Pharma GmbH's procurement strategy.

3Market Positioning

Based on its product mix, VPG Venus Pharma GmbH serves the hospital and clinical segments of the German pharmaceutical market. By importing advanced antibiotics, the company positions itself as a critical supplier of essential medications needed to treat severe infections and manage antibiotic resistance. This strategic focus enables VPG Venus Pharma GmbH to meet the specialized needs of healthcare institutions and contribute to the overall quality of patient care in Germany.

Seller's Guide — How to Become a Supplier to VPG Venus Pharma Gmbham Bahnhof

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

For new Indian suppliers, establishing a partnership with VPG Venus Pharma GmbH presents a significant opportunity to enter the German market. However, the existing supplier concentration with Venus Remedies Limited may pose challenges in forming new relationships. To identify potential gaps in VPG Venus Pharma GmbH's current sourcing, a detailed analysis of their product portfolio and supply chain dynamics is necessary. Exploring therapeutic areas or product forms not currently covered could provide avenues for new suppliers to offer complementary products.

2Requirements & Qualifications

Indian exporters aiming to supply VPG Venus Pharma GmbH must ensure their products have valid marketing authorizations from BfArM and comply with EU-GMP standards. Additionally, adherence to EU regulations regarding labeling, serialization, and environmental sustainability is essential. Establishing a robust quality management system and maintaining consistent product quality are critical to meet the expectations of both VPG Venus Pharma GmbH and the German regulatory authorities.

3How to Approach

Frequently Asked Questions — VPG Venus Pharma Gmbham Bahnhof

What products does VPG Venus Pharma Gmbham Bahnhof import from India?

VPG Venus Pharma Gmbham Bahnhof imports 2 pharmaceutical products across 1 categories. Top imports: Meropenem ($750.0K), Ceftazidime ($109.1K).

Who supplies pharmaceuticals to VPG Venus Pharma Gmbham Bahnhof from India?

VPG Venus Pharma Gmbham Bahnhof sources from 1 verified Indian suppliers. The primary supplier is Venus Remedies Limited (100.0% of imports, $864.0K).

What is VPG Venus Pharma Gmbham Bahnhof's total pharmaceutical import value?

VPG Venus Pharma Gmbham Bahnhof's total pharmaceutical import value from India is $859.1K, based on 19 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does VPG Venus Pharma Gmbham Bahnhof focus on?

VPG Venus Pharma Gmbham Bahnhof imports across 1 categories. The largest: Advanced Antibiotics (100.0%).

Get Full VPG Venus Pharma Gmbham Bahnhof Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.